Previous Page  3 / 33 Next Page
Information
Show Menu
Previous Page 3 / 33 Next Page
Page Background

Page 55

Notes:

conferenceseries

.com

Volume 5, Issue 6(Suppl)

J Infect Dis Ther, an open access journal

ISSN: 2332-0877

Euro Infectious Diseases 2017

September 07-09, 2017

September 07-09, 2017 | Paris, France

Infectious Diseases

6

th

Euro-Global Conference on

Chitosan and silver nanoparticles: Promising antitoxoplasma agents

Maha Gaafar, Mady R F, Diab RG

and

Shalaby Th I

Alexandria University, Egypt

T

oxoplasmosis is a worldwide infection caused by obligate intracellular protozoan parasite which is

Toxoplasma gondii

.

Chitosan and silver nanoparticles were synthesized to be evaluated singly or combined for their antitoxoplasma effects

as prophylaxis and as treatment in the experimental animals. Results were assessed through studying the parasite density,

studying the ultrastructural parasite changes and estimation of serum gamma interferon. Weight of tissue silver was assessed in

different organs. Results showed that silver nanoparticles used singly or combined with chitosan have promising antitoxoplasma

potentials. The animals that received these compounds showed statistically significant decrease in the mean number of the

parasite count in the liver and the spleen, when compared to the corresponding control group. Light microscopic examination

of the peritoneal exudates of animals receiving these compounds showed stoppage of movement and deformity in shape of

the tachyzoites, whereas, by Scanning Electron Microscope, the organisms were mutilated. Moreover, gamma interferon was

increased in the serum of animals receiving these compounds. All values of silver detected in different tissues were within the

safe range. Thus, these nanoparticles proved their effectiveness against the experimental Toxoplasma infection.

Biography

Gaafar M R has her expertise in diagnosis of different parasitic infections in various samples; blood, stool, urine and aspirates using novel and rapid techniques

as enzymatic assays and real-time PCR. Her trials in treatment of the most common infectious diseases based on the use of new and safe lines of treatment as

herbal treatment as well as the use of nanoparticles either natural or metal as anti-parasitic agents.

drmahagaafar@yahoo.com

Maha Gaafar et al., J Infect Dis Ther 2017, 5:6(Suppl)

DOI: 10.4172/2332-0877-C1-033